Who has invested in BlossomHill Therapeutics?

Colt Ventures, Cormorant Asset Management, OrbiMed, Vivo Capital, Janus Henderson Investors, Brahma Capital are named among the investors backing BlossomHill Therapeutics.

BlossomHill Therapeutics Funding: $173M Raised, Series B

BlossomHill Therapeutics funding overview

BlossomHill Therapeutics is a Biotech company based in San Diego, CA. BlossomHill Therapeutics has raised $173M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in December 2025. The round record for BlossomHill Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Colt Ventures, Cormorant Asset Management, OrbiMed, Vivo Capital, Janus Henderson Investors, Brahma Capital and 4 others. 10 distinct backers are named across the disclosed rounds.

BlossomHill Therapeutics at a glance

Total raised: $173M
Latest round: Series B
Latest round date: December 2025
Industry: Biotech
Headquarters: San Diego, CA
Notable investors: Colt Ventures, Cormorant Asset Management, OrbiMed, Vivo Capital, Janus Henderson Investors, Brahma Capital, BioTrack Capital, Plaisance Capital Management LLC

Frequently asked about BlossomHill Therapeutics funding

How much has BlossomHill Therapeutics raised?: BlossomHill Therapeutics has raised $173M in total disclosed funding across the rounds on record.
Who has invested in BlossomHill Therapeutics?: Colt Ventures, Cormorant Asset Management, OrbiMed, Vivo Capital, Janus Henderson Investors, Brahma Capital are named among the investors backing BlossomHill Therapeutics.
What was the latest BlossomHill Therapeutics funding round?: The most recent disclosed round is a Series B, announced in December 2025.
Where is BlossomHill Therapeutics based?: BlossomHill Therapeutics is based in San Diego, CA.
What sector does BlossomHill Therapeutics operate in?: BlossomHill Therapeutics is tracked under Biotech from San Diego, CA, with $173M in disclosed funding.
When did BlossomHill Therapeutics last raise?: The last disclosed BlossomHill Therapeutics round closed in December 2025 at Series B.

Totals shown for BlossomHill Therapeutics aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in San Diego and the investors behind them below.

BlossomHill Therapeutics Funding: $173M Raised, Series B

BlossomHill Therapeutics funding overview

BlossomHill Therapeutics at a glance

Frequently asked about BlossomHill Therapeutics funding

Companies related to BlossomHill Therapeutics (37)

Browse related funding lists (8)